Skip to main content
PharmaTher Holdings Ltd. logo

PharmaTher Holdings Ltd. — Investor Relations & Filings

Ticker · PHRM ISIN · CA71716H1082 LEI · 529900PIPSZ1ZSWF3A21 CSE Manufacturing
Open in API
Filings indexed 279 across all filing types
Latest filing 2021-10-19 Regulatory Filings
Country CA Canada
Listing CSE PHRM

About PharmaTher Holdings Ltd.

https://www.pharmather.com/

PharmaTher Holdings Ltd. is a specialty pharmaceutical company dedicated to the research, development, and commercialization of novel therapeutics, primarily focusing on ketamine and psychedelic compounds. The company's strategy involves advancing three core assets: the KETARX™ portfolio of ketamine drugs, which targets neuropsychiatric and pain disorders; the proprietary PharmaPatch™ microneedle patch platform, designed for the transdermal delivery of ketamine, psychedelics, and GLP-1 drugs; and a 49% ownership interest in Sairiyo Therapeutics Inc., which is developing a patented oral formulation of cepharanthine for infectious diseases and cancer. PharmaTher is focused on achieving regulatory approval for its pipeline candidates to address significant global unmet medical needs in mental health, neurological, and pain disorders.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing a manufacturing agreement between PharmaTher Holdings Ltd. and Alcami Corporation for clinical and commercial manufacturing of ketamine products. It discusses the company's plans for FDA Phase 3 clinical studies and commercialization but does not contain any financial statements, regulatory filings, or detailed financial data. The content is primarily a corporate announcement about a partnership and manufacturing arrangement, not a financial report, earnings release, or regulatory filing. It is not a report publication announcement since it does not mention the release or availability of a report. Therefore, the document best fits the category of a general regulatory announcement or corporate news that does not fit other specific categories, which corresponds to Regulatory Filings (RNS).
2021-10-19 English
News release - English.pdf
Regulatory Filings
2021-10-13 English
News release - English.pdf
Regulatory Filings Classification · 90% confidence The document is a press release announcing the initiation of a Phase 2 clinical trial by PharmaTher Holdings Ltd. It discusses the clinical trial design, objectives, and regulatory approval (FDA IND approval). There is no financial data, no discussion of financial results, no shareholder voting information, no management changes, no earnings data, and no regulatory filings or certifications. The content is focused on a clinical trial initiation announcement, which is a corporate news update rather than a financial or regulatory filing. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Regulatory Filings. Given the nature of the document as a corporate announcement about clinical trial initiation, the best fitting category is Regulatory Filings (RNS) as a general announcement that does not fit other specific categories.
2021-10-06 English
Other.pdf
Capital/Financing Update Classification · 95% confidence The document is titled 'SECURITIES PURCHASE AGREEMENT' and contains detailed terms and definitions related to the issuance and sale of securities by PharmaTher Holdings Ltd. It includes sections on purchase and sale, definitions of securities, closing conditions, and references to securities laws and regulatory bodies such as the Securities Act of 1933 and the SEC. The content is a legal contract governing a financing transaction rather than a report or announcement. It is not an annual report, earnings release, or any form of regulatory filing announcing results or changes. Instead, it is a capital raising agreement outlining the terms of a securities issuance. Therefore, the document fits the category of Capital/Financing Update (CAP). The document length (15,000 characters) and detailed content support this classification with high confidence.
2021-09-30 English
Material change report - English.pdf
Capital/Financing Update Classification · 100% confidence The document is a Form 51-102F3 Material Change Report, which is a regulatory filing used to disclose significant corporate events or changes. The content describes the closing of a CAD$10 million private placement financing, including details about the shares and warrants issued, the use of proceeds, and the placement agent's compensation. This is a clear update on the company's capital raising activity. The document is not a full financial report, earnings release, or management discussion, but rather an announcement of a financing event. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length (6990 characters) supports it being a substantive announcement rather than a brief notice or report publication announcement.
2021-09-29 English
Material change report - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a Form 51-102F3 Material Change Report, which is a regulatory filing used in Canadian securities regulation to disclose material changes in a company. The content includes a news release about a private placement financing of CAD$10 million, describing the issuance of common shares and warrants. The document does not contain detailed financial statements or comprehensive financial analysis but rather announces a financing event. It is not an annual or interim report, audit report, or earnings release. It is not a proxy, governance, or management report. The document is primarily an announcement of a material change related to capital raising. According to the filing definitions, updates on company fundraising or financing activities fall under Capital/Financing Update (CAP). The document length is 6866 characters, which is sufficient to contain substantive information about the financing. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2021-09-29 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.